|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
|
|---|---|---|---|---|---|---|
| Assets | ||||||
| Current assets | ||||||
| Cash | ||||||
| Prepaid expenses | ||||||
| Total Current Assets | ||||||
| Long-term prepaid insurance | ||||||
| Investments held in Trust Account | ||||||
| Total Assets | ||||||
| Liabilities, Class A Ordinary Shares Subject to Possible Redemption, and Shareholders’ Deficit | ||||||
| Current liabilities | ||||||
| Accrued offering costs | ||||||
| Accounts payable and accrued expenses | ||||||
| Total current liabilities | ||||||
| Deferred underwriting fee | ||||||
| Total Liabilities | ||||||
| Class A Ordinary Shares subject to possible redemption, 25,300,000 shares at redemption value of $10.52 and $10.25 per share as of September 30, 2026 and December 31, 2025, respectively (Note 6) | ||||||
| Shareholders’ Deficit | ||||||
| Ordinary shares value | ||||||
| Class A Ordinary Shares | ||||||
| Class B Ordinary Shares | ||||||
| Accumulated deficit | ||||||
| Total Shareholders’ Deficit | ||||||
| Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption, and Shareholders’ Deficit |
Loading...